Recent research highlights the pivotal role of ELOVL1 in T cell cholesterol metabolism and its implications for enhancin...
Tailored antisense oligonucleotides (ASOs) are changing the future of rare genetic disease therapies
Rare diseases affect hundreds of millions worldwide, with most cases having genetic origins and primarily impacting chil...
New breakthroughs in early-onset dementia: progranulin therapies show promise
A groundbreaking development in the fight against frontotemporal dementia (FTD) is opening up new avenues for drug disco...
Innovating Protease Inhibition: Advancing Targeted Therapies for Disease Treatment
Protease inhibition faces challenges due to specificity and safety concerns. Innovative approaches, including non-natura...
ENEA Tech and Biomedical Foundation: €160 Million for Precision Medicine, Digital Health, Agritech, Industrial Research, and Experimental Development in Life Sciences
In 2024, the Foundation has allocated approximately €80 million from the Biomedical Fund to invest in 16 innovative st...
Harnessing Artificial Intelligence to Unlock the Therapeutic Potential of Plant Bioactives
A Revolutionary Approach to Biodiversity Conservation, Medicinal Discovery, and Sustainable Botanical Production “...